MedAssets (MDAS) Inactive 10-Q4 Aug 142014 Q2 Quarterly reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2014	Jul. 24, 2014
Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Jun-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q2	'
Entity Registrant Name	'MEDASSETS INC	'
Entity Central Index Key	'0001254419	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	60,099,617

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Current assets	'	'
Cash and cash equivalents	$6,004	$2,790
Accounts receivable, net of allowances of $2,627 and $2,568 as of June 30, 2014 and December 31, 2013, respectively	97,901	87,636
Deferred tax asset, current portion	1,269	4,535
Prepaid expenses and other current assets	26,795	24,059
Total current assets	131,969	119,020
Property and equipment, net	160,274	157,747
Other long term assets	'	'
Goodwill	1,027,847	1,027,847
Intangible assets, net	239,387	267,440
Other	41,063	41,695
Other long term assets	1,308,297	1,336,982
Total assets	1,600,540	1,613,749
Current liabilities	'	'
Accounts payable	16,609	24,066
Accrued revenue share obligation and rebates	77,697	77,398
Accrued payroll and benefits	29,511	41,587
Other accrued expenses	12,154	12,126
Deferred revenue, current portion	55,645	46,523
Current portion of notes payable	18,625	15,500
Current portion of finance obligation	280	255
Total current liabilities	210,521	217,455
Notes payable, less current portion	443,125	424,000
Bonds payable	325,000	325,000
Finance obligation, less current portion	8,625	8,781
Deferred revenue, less current portion	17,233	16,369
Deferred tax liability	113,041	121,083
Other long term liabilities	10,900	11,272
Total liabilities	1,128,445	1,123,960
Commitments and contingencies	'	'
Stockholders' equity	'	'
Common stock, $0.01 par value, 150,000,000 shares authorized; 60,089,000 and 61,740,000 shares issued and outstanding as of June 30, 2014 and December 31, 2013, respectively	601	617
Additional paid-in capital	685,180	717,132
Accumulated deficit	-213,686	-227,960
Total stockholders' equity	472,095	489,789
Total liabilities and stockholders' equity	$1,600,540	$1,613,749

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Statement Of Financial Position [Abstract]	'	'
Allowances on accounts receivable	$2,627	$2,568
Common stock, par value	$0.01	$0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	60,089,000	61,740,000
Common stock, shares outstanding	60,089,000	61,740,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Revenue:	'	'	'	'
Administrative fees, net	$70,091	$70,502	$146,337	$147,021
Other service fees	105,324	100,240	199,945	196,558
Total net revenue	175,415	170,742	346,282	343,579
Operating expenses:	'	'	'	'
Cost of revenue (inclusive of amortization expense of $648 and $571 for the three months ended June 30, 2014 and 2013, respectively; and $1,072 and $1,169 for the six months ended June 30, 2014 and 2013, respectively)	40,361	37,496	77,792	71,764
Product development expenses	6,642	7,975	14,039	16,476
Selling and marketing expenses	20,721	20,285	35,914	34,027
General and administrative expenses	59,529	57,199	118,332	115,819
Restructuring, acquisition and integration-related expenses	0	1,435	1,697	9,465
Depreciation	11,862	9,876	23,402	19,053
Amortization of intangibles	14,027	16,115	28,053	32,616
Total operating expenses	153,142	150,381	299,229	299,220
Operating income	22,273	20,361	47,053	44,359
Other income (expense):	'	'	'	'
Interest (expense)	-11,114	-12,381	-22,287	-23,730
Other income	31	276	89	317
Income before income taxes	11,190	8,256	24,855	20,946
Income tax expense	4,594	3,172	10,581	8,158
Net income	$6,596	$5,084	$14,274	$12,788
Basic and diluted income per share:	'	'	'	'
Basic net income per share	$0.11	$0.09	$0.24	$0.22
Diluted net income per share	$0.11	$0.08	$0.23	$0.21
Weighted average shares-basic	59,752	59,387	60,189	59,198
Weighted average shares-diluted	60,946	60,665	61,419	60,628

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Statement [Abstract]	'	'	'	'
Amortization expense	$648	$571	$1,072	$1,169

Condensed_Consolidated_Stateme2

Condensed Consolidated Statement of Stockholders' Equity (Unaudited) (USD $)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
In Thousands, except Share data	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Balances at Dec. 31, 2013	$489,789	$617	$717,132	($227,960)
Balances, Shares at Dec. 31, 2013	61,740,000	61,740,000	'	'
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net	2,559	3	2,556	'
Issuance of common stock from stock option and SSAR exercises and restricted stock issuances, net, Shares	'	251,000	'	'
Shares surrendered to pay taxes on vesting of restricted stock	-2,832	-1	-2,831	'
Shares surrendered to pay taxes on vesting of restricted stock, Shares	'	-118,000	'	'
Stock compensation expense	9,894	'	9,894	'
Repurchase of common stock	-42,759	-18	-42,741	'
Repurchase of common stock, Shares	-1,784,145	-1,784,000	'	'
Excess tax benefit from equity award exercises, net	1,170	'	1,170	'
Net income	14,274	'	'	14,274
Balances at Jun. 30, 2014	$472,095	$601	$685,180	($213,686)
Balances, Shares at Jun. 30, 2014	60,089,000	60,089,000	'	'

Condensed_Consolidated_Stateme3

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Operating activities	'	'
Net income	$14,274	$12,788
Adjustments to reconcile income from continuing operations to net cash provided by operating activities:	'	'
Bad debt expense	100	'
Depreciation	24,474	20,222
Amortization of intangibles	28,053	32,616
Impairment of assets	'	2,403
Loss (gain) on sale of assets	16	-123
Noncash stock compensation expense	9,894	7,422
Excess tax benefit from exercise of equity awards	-1,557	-3,035
Amortization of debt issuance costs	1,880	1,908
Noncash interest expense, net	208	239
Deferred income tax benefit	-4,837	-2,560
Changes in assets and liabilities:	'	'
Accounts receivable	-10,365	1,077
Prepaid expenses and other assets	-2,736	1,064
Other long-term assets	477	-311
Accounts payable	-6,889	-1,675
Accrued revenue share obligations and rebates	299	3,813
Accrued payroll and benefits	-12,077	-10,267
Other accrued expenses and long-term liabilities	-411	5,184
Deferred revenue	9,986	-3,181
Cash provided by operating activities	50,789	67,584
Investing activities	'	'
Purchases of property, equipment and software, net	-7,201	-5,328
Capitalized software development costs	-20,878	-18,861
Cash used in investing activities	-28,079	-24,189
Financing activities	'	'
Borrowings from revolving credit facility	74,080	'
Repayment of notes payable	-17,750	-62,750
Repayment of revolving credit facility	-34,080	'
Repayment of finance obligation	-338	-338
Excess tax benefit from exercise of equity awards	1,557	3,035
Issuance of common stock, net of offering costs	2,559	3,640
Purchase of treasury shares, including shares surrendered for tax withholdings	-45,524	'
Cash used in financing activities	-19,496	-56,413
Net increase (decrease) in cash and cash equivalents	3,214	-13,018
Cash and cash equivalents, beginning of period	2,790	13,734
Cash and cash equivalents, end of period	$6,004	$716

BUSINESS_DESCRIPTION_AND_BASIS

BUSINESS DESCRIPTION AND BASIS OF PRESENTATION	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
BUSINESS DESCRIPTION AND BASIS OF PRESENTATION	'
	1	BUSINESS DESCRIPTION AND BASIS OF PRESENTATION
	We provide technology-enabled products and services which together deliver solutions designed to reduce total cost of care, enhance operational efficiency, align clinical delivery with advance care coordination and improve revenue performance for hospitals, health systems and other ancillary healthcare providers. Our client-specific solutions are designed to efficiently analyze detailed information across the spectrum of cost, operations, clinical delivery and reimbursement. Our solutions integrate with existing operations and enterprise software systems of our clients and provide financial improvement with minimal upfront costs or capital expenditures. Our operations and clients are primarily located throughout the United States and to a limited extent, Canada.
	The accompanying unaudited condensed consolidated financial statements, and condensed consolidated balance sheet as of December 31, 2013, derived from audited financial statements, have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial reporting and as required by Regulation S-X, Rule 10-01 of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, certain information and footnote disclosures required for complete financial statements are not included herein. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation of the interim financial information have been included. When preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures at the date of the financial statements. Actual results could differ materially from those estimates. Operating results for the three and six months ended June 30, 2014 are not necessarily indicative of the results that may be expected for any other interim period or for the fiscal year ending December 31, 2014.
	The accompanying unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the audited consolidated financial statements for the year ended December 31, 2013 included in our Form 10-K as filed with the SEC on March 3, 2014. These financial statements include the accounts of MedAssets, Inc. and our wholly owned subsidiaries. All significant intercompany accounts have been eliminated in consolidation.
	Use of Estimates
	The preparation of the financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from those estimates. We believe that the estimates, assumptions and judgments involved in revenue recognition, allowances for doubtful accounts and returns, product development costs, share-based payments, business combinations, impairment of goodwill, intangible assets and long-lived assets, and accounting for income taxes have the greatest potential impact on our condensed consolidated financial statements.
	Cash and Cash Equivalents
	All of our highly liquid investments with original maturities of three months or less at the date of purchase are carried at cost which approximates fair value and are considered to be cash equivalents. Currently, our excess cash is voluntarily used to repay our swing line credit facility, if any, on a daily basis and applied against our revolving credit facility on a routine basis when our swing line credit facility is undrawn. In addition, we may periodically make voluntary repayments on our term loans.
	Cash and cash equivalents were $6,004 and $2,790 as of June 30, 2014 and December 31, 2013, respectively. We had $50,000 and $10,000 outstanding on our revolving credit facility as of June 30, 2014 and December 31, 2013, respectively. In the event our cash balance is zero at the end of a period, any outstanding checks are recorded as accrued expenses. See Note 5 for immediately available cash under our revolving credit facility.
	Additionally, we have a concentration of credit risk arising from cash deposits held in excess of federally insured amounts totaling $5,504 as of June 30, 2014.

RECENT_ACCOUNTING_PRONOUNCEMEN

RECENT ACCOUNTING PRONOUNCEMENTS	6 Months Ended
	Jun. 30, 2014
Accounting Changes And Error Corrections [Abstract]	'
RECENT ACCOUNTING PRONOUNCEMENTS	'
	2	RECENT ACCOUNTING PRONOUNCEMENTS
	Share-Based Compensation
	In June 2014, the Financial Accounting Standards Board (“FASB”) issued an accounting standard update relating to reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. This update requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. The update will be effective on January 1, 2016.
	Revenue Recognition
	In May 2014, the FASB issued an accounting standard update relating to revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The update will replace most existing revenue recognition guidance under generally accepted accounting principles when it becomes effective. The update is effective for us on January 1, 2017. Early application is not permitted. The update permits the use of either the retrospective or cumulative effect transition method. We are evaluating the effect that the update will have on our consolidated financial statements and related disclosures. We have not yet selected a transition method nor have we determined the effect of the standard on our ongoing financial reporting.
	Discontinued Operations
	In April 2014, the FASB issued an accounting standard update which revises what qualifies as a discontinued operation and changes the criteria for determining which disposals can be presented as discontinued operations and modifies related disclosure requirements. This update will be effective for applicable transactions occurring after January 1, 2015.
	Income Taxes
	In July 2013, the FASB issued an accounting standard update relating to the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This update amends existing GAAP that required in certain cases, an unrecognized tax benefit, or portion of an unrecognized tax benefit, to be presented in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward when such items exist in the same taxing jurisdiction. The amendments in this update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. The amendments should be applied prospectively to all unrecognized tax benefits that exist at the effective date, and retrospective application is permitted. We adopted this update on January 1, 2014.
	Obligations Resulting from Joint and Several Liability Arrangements
	In February 2013, the FASB issued guidance for the recognition, measurement and disclosure of obligations resulting from joint and several liability arrangements for which the total amount of the obligation within the scope of the guidance is fixed at the reporting date. Examples of obligations within the scope of this update include debt arrangements, other contractual obligations and settled litigation and judicial rulings. The guidance requires an entity to measure such obligations as the sum of the amount that the reporting entity agreed to pay on the basis of its arrangement among its co-obligors plus additional amounts the reporting entity expects to pay on behalf of its co-obligors. The guidance in the update also requires an entity to disclose the nature and amount of the obligation as well as other information about those obligations. The update is effective for fiscal years, and interim periods within those years, beginning after December 15, 2013. We adopted this update on January 1, 2014.

RESTRUCTURING_ACQUISITION_AND_

RESTRUCTURING, ACQUISITION AND INTEGRATION-RELATED EXPENSES	6 Months Ended
	Jun. 30, 2014
Text Block [Abstract]	'
RESTRUCTURING, ACQUISITION AND INTEGRATION-RELATED EXPENSES	'
	3	RESTRUCTURING, ACQUISITION AND INTEGRATION-RELATED EXPENSES
	Restructuring Activities
	Restructuring charges consist of exit costs and other costs associated with the reorganization of our operations, including employee termination costs, lease contract termination costs, impairment of assets, and any other qualifying exit costs. Costs associated with exit or disposal activities are recorded when the liability is incurred or when such costs are deemed probable and estimable and represent management’s best estimate.

	In January 2014, our management approved and initiated a plan to restructure our operations resulting in certain workforce changes within the Company that resulted in costs of approximately $1,697. During the three months ended June 30, 2014 and 2013, we expensed restructuring and exit and integration-related costs of zero and $1,435, respectively. During the six months ended June 30, 2014 and 2013, we expensed restructuring and exit and integration-related costs of $1,697 and $9,465, respectively. These costs are included within the restructuring, acquisition and integration-related expenses line on the accompanying condensed consolidated statements of operations. As of June 30, 2014, cash payments were made of approximately $1,923 and we had approximately $394 included in current liabilities for these employee-related costs that we expect to pay over the next twelve months.

DEFERRED_REVENUE

DEFERRED REVENUE	6 Months Ended
DEFERRED REVENUE	Jun. 30, 2014
Deferred Revenue Disclosure [Abstract]	'
DEFERRED REVENUE	'
	4	DEFERRED REVENUE
	Deferred revenue consists of unrecognized revenue related to advanced client billing or client payments received prior to revenue being realized and earned. Substantially all of our deferred revenue consists of: (i) deferred administrative fees, net; (ii) deferred service fees; (iii) deferred software and implementation fees; and (iv) other deferred fees, including receipts for our annual customer and vendor meeting prior to the event.
	The following table summarizes the deferred revenue categories and balances as of:


			June 30,		December 31,
			2014		2013
	Software and implementation fees		$	34,097	$	27,393
	Service fees			23,804		22,363
	Administrative fees			11,748		10,935
	Other fees			3,229		2,201

	Deferred revenue, total			72,878		62,892
	Less: Deferred revenue, current portion			(55,645)		(46,523)

	Deferred revenue, non-current portion		$	17,233	$	16,369

	As of June 30, 2014 and December 31, 2013, deferred revenue included in our condensed consolidated balance sheets that was contingent upon meeting performance targets was $4,728 and $6,516, respectively. Advance billings on arrangements that include contingent performance targets are recorded in accounts receivable and deferred revenue when billed. Only certain contingent performance targets are billed in advance of meeting the target as determined by the customer arrangement.

NOTES_AND_BONDS_PAYABLE

NOTES AND BONDS PAYABLE	6 Months Ended
NOTES AND BONDS PAYABLE	Jun. 30, 2014
Debt Disclosure [Abstract]	'
NOTES AND BONDS PAYABLE	'
	5	NOTES AND BONDS PAYABLE
	The balances of our notes and bonds payable are summarized as follows as of:


			June 30,		December 31,
			2014		2013
	Term A facility		$	231,250	$	237,500
	Term B facility			180,500		192,000
	Revolving credit facility			50,000		10,000

	Total notes payable			461,750		439,500
	Bonds payable			325,000		325,000

	Total notes and bonds payable			786,750		764,500
	Less: current portions			(18,625)		(15,500)

	Total long-term notes and bonds payable		$	768,125	$	749,000

	Notes Payable
	As of June 30, 2014, our long-term notes payable consists of a Term A Facility, a Term B Facility and a revolving credit facility under a credit agreement with JP Morgan Chase Bank, N.A and other financial institutions named therein, dated December 13, 2012 (the “Credit Agreement”), each with an outstanding balance of $231,250, $180,500 and $50,000, respectively. We have classified the $50,000 outstanding balance on our revolving credit facility as a long term liability given the maturity date of December 13, 2017. No amounts were drawn on our swing line loan, which resulted in $149,000 of availability under our revolving credit facility (after giving effect to $1,000 of outstanding but undrawn letters of credit on such date) as of June 30, 2014. During the six months ended June 30, 2014, we made scheduled principal payments of $7,750 on our Term A Facility and Term B Facility in addition to $10,000 in voluntary prepayments on our Term B Facility. The applicable weighted average interest rates (inclusive of the applicable bank margin) on our Term A Facility, Term B Facility and Revolving Credit Facility at June 30, 2014 were 2.49%, 4.00% and 2.49%, respectively.
	The Credit Agreement contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on fundamental changes, limitations on asset sales and sale leasebacks, limitations on investments, limitations on dividends or distributions on, or redemptions of, equity interests, limitations on prepayments or redemptions of unsecured or subordinated debt, limitations on negative pledge clauses, limitations on transactions with affiliates and limitations on changes to the Company’s fiscal year. The Credit Agreement also includes maintenance covenants of maximum ratios of consolidated total indebtedness (subject to certain adjustments) to consolidated EBITDA (subject to certain adjustments) and minimum cash interest coverage ratios. The Credit Agreement contains certain customary representations and warranties, affirmative covenants and events of default, including but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, cross-defaults to certain indebtedness, certain events of insolvency or bankruptcy, material judgments, certain events under ERISA, actual or asserted failures of any guaranty or security document supporting the credit agreement to be in full force and effect and changes of control. The Company was in compliance with these covenants as of June 30, 2014. We are also required to prepay our debt obligations based on an excess cash flow calculation for the applicable fiscal year which is determined in accordance with the terms of the Credit Agreement. Our current portion of notes payable does not include an amount with respect to any 2014 excess cash flow payment. We will reclassify a portion of our long-term notes payable to a current classification at such time that any 2014 excess cash flow payment becomes estimable. We will be required to make any necessary cash flow payment within the first quarter of 2015.
	All of the Company’s obligations under the Credit Agreement are unconditionally guaranteed by each of the Company’s existing and subsequently acquired or organized wholly-owned restricted subsidiaries, except that the following subsidiaries do not and will not provide guarantees: (a) unrestricted subsidiaries, (b) subsidiaries with tangible assets and revenues each having a value of less than 2.5% of the consolidated tangible assets and consolidated revenues of the Company (provided that all such immaterial subsidiaries, on a consolidated basis, shall not account for more than 5.0% of the consolidated EBITDA of the Company), (c) any subsidiary prohibited by applicable law, rule or regulation from providing a guarantee or which would require governmental (including regulatory) consent or approval or which would result in adverse tax consequences and (d) not-for-profit subsidiaries.
	All of the Company’s obligations under the Credit Agreement are secured by substantially all of the Company’s assets and the assets of each guarantor (subject to certain exceptions), including but not limited to, (1) a perfected pledge of all of the equity securities of each direct wholly owned restricted subsidiary of the Company and of each subsidiary guarantor (which pledge, in the case of any foreign subsidiary, is limited to 65% of the equity securities of such foreign subsidiary) and (2) perfected security interests in, and mortgages on, substantially all tangible and intangible personal property and material fee-owned real property of the Company and each subsidiary guarantor (including but not limited to, accounts receivable, inventory, equipment, general intangibles (including contract rights), investment property, intellectual property, material intercompany notes and proceeds of the foregoing).
	Loans under the Credit Agreement must be prepaid under certain circumstances, including with proceeds from certain future debt issuances, asset sales and a portion of excess cash flow for the applicable fiscal year. Loans under the Credit Agreement may be voluntarily prepaid at any time, subject to customary LIBOR breakage costs.
	Bonds Payable
	In November 2010, we closed the offering of an aggregate principal amount of $325,000 of senior notes due 2018 (the “Notes”) in a private placement (the “Notes Offering”). In October 2011, our Notes were registered under the Securities Act of 1933, as amended. The Notes are guaranteed on a senior unsecured basis by each of our existing domestic subsidiaries and each of our future domestic restricted subsidiaries in each case that guarantees our obligations under the credit agreement. Each of the subsidiary guarantors is 100% owned by us; the guarantees by the subsidiary guarantors are full and unconditional; the guarantees by the subsidiary guarantors are joint and several; we have no independent assets or operations; and any subsidiaries of ours other than the subsidiary guarantors are minor. The Notes and the guarantees are senior unsecured obligations of the Company and the subsidiary guarantors, respectively.
	The Notes were issued pursuant to an indenture dated as of November 16, 2010 (the “Indenture”) among the Company, its subsidiary guarantors and Wells Fargo Bank, N.A., as trustee. Pursuant to the Indenture, the Notes will mature on November 15, 2018 and bear 8% annual interest. Interest on the Notes is payable semi-annually in arrears on May 15 and November 15 of each year, beginning on May 15, 2011.

	The Indenture contains certain customary negative covenants, including but not limited to, limitations on the incurrence of debt, limitations on liens, limitations on consolidations or mergers, limitations on asset sales, limitations on certain restricted payments and limitations on transactions with affiliates. The Indenture does not contain any significant restrictions on the ability of the Company or any subsidiary guarantor to obtain funds from the Company or any other subsidiary guarantor by dividend or loan. The Indenture also contains customary events of default. The Company was in compliance with these covenants as of June 30, 2014.
	The Company has the option to redeem the Notes as follows: (i) at any time prior to November 15, 2014, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount plus the applicable premium (as defined in the Indenture); and (ii) on and after November 15, 2014, the Company may redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104%
	2015			102%
	2016 and thereafter			100%
	The Notes also contain a redemption feature that would require the repurchase of 101% of the aggregate principal amount plus accrued and unpaid interest at the option of the holders upon a change in control.
	As of June 30, 2014, the Company’s 8% senior notes due 2018 were trading at 105.8% of par value (Level 1).
	Debt Issuance Costs
	As of June 30, 2014, we had approximately $15,385 of debt issuance costs related to the Credit Agreement and Notes which will be amortized into interest expense generally using the effective interest method until the applicable maturity date. For the three months ended June 30, 2014 and 2013, we recognized $937 and $955, respectively, in interest expense related to the amortization of debt issuance costs. For the six months ended June 30, 2014 and 2013, we recognized $1,880 and $1,908, respectively, in interest expense related to the amortization of debt issuance costs.
	Debt Maturity Table
	The following table summarizes our stated debt maturities and scheduled principal repayments as of June 30, 2014:


	Year		Term A Facility		Term B Facility		Revolving Credit		Senior		Total
	Year		Term A Facility		Term B Facility		Facility		Unsecured Notes		Total
	2014		$	6,250	$	1,500	$	-	$	-	$	7,750	(1)
	2015			18,750		3,000		-		-		21,750
	2016			25,000		3,000		-		-		28,000
	2017			181,250		3,000		50,000		-		234,250
	2018			-		3,000		-		325,000		328,000
	Thereafter			-		167,000		-		-		167,000

			$	231,250	$	180,500	$	50,000	$	325,000	$	786,750


		-1	Represents the remaining quarterly principal payments due during the fiscal year ending December 31, 2014 and the balance of the swing line component of our revolving credit facility, if any.
	Total interest paid (net of amounts capitalized) on our notes and bonds payable during the six months ended June 30, 2014 and 2013 was approximately $20,058 and $23,577, respectively.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2014
Commitments And Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	6	COMMITMENTS AND CONTINGENCIES
	Performance Targets
	In the ordinary course of contracting with our clients, we may agree to make some or all of our fees contingent upon the client’s achievement of financial improvement targets from the use of our services and software. These contingent fees are not recognized as revenue until the client confirms achievement of the performance targets. We generally receive client acceptance as and when the performance targets are achieved. If we invoice contingent fees prior to client confirmation that a performance target has been achieved, we record invoiced contingent fees as deferred revenue on our condensed consolidated balance sheet. Often, recognition of this revenue occurs in periods subsequent to the recognition of the associated costs.
	Legal Proceedings
	From time to time, we become involved in legal proceedings arising in the ordinary course of business. As of June 30, 2014, we are not presently involved in any legal proceedings, the outcome of which, if determined adversely to us, would have a material adverse effect on our business, operating results or financial condition.

STOCKHOLDERS_EQUITY_AND_SHAREB

STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION	6 Months Ended
STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION	Jun. 30, 2014
Text Block [Abstract]	'
STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION	'
	7	STOCKHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION
	Common Stock
	During the six months ended June 30, 2014, we issued approximately 295,000 shares of common stock in connection with employee stock option exercises, stock-settled stock appreciation rights (“SSARs”) exercises and the vesting of restricted stock units (“RSUs”) for net exercise proceeds of $2,559.
	During the six months ended June 30, 2014, approximately 44,000 shares of restricted common stock were forfeited.
	During the six months ended June 30, 2014, we received approximately 118,000 restricted shares that were surrendered from equity awards holders to settle their associated minimum statutory tax liability of $2,832 from shares that vested during the year.
	Repurchase of Common Stock
	On February 26, 2014, our Board of Directors authorized a share repurchase program of up to $75,000 of our common stock. The following table shows the amount and cost of shares of common stock we repurchased for the three and six months ended June 30, 2014 under the share repurchase program. The repurchased shares have not been retired and constitute authorized but unissued shares.


			Three months ended June 30,				Six months ended June 30,
			2014		2013		2014		2013
	Number of shares repurchased			1,144,145		-		1,784,145		-
	Cost of shares repurchased(1)		$	26,699	$	-	$	42,759	$	-

		-1	Our share repurchase program required a three-day cash settlement period with our broker. We made purchases at the end of June 2014 amounting to 3,071 shares totaling approximately $67, which were settled in July 2014. The cost of these shares is included in other accrued expenses on our Condensed Consolidated Balance Sheet as of June 30, 2014.
	Share-Based Compensation
	As of June 30, 2014, we had restricted common stock, RSUs, SSARs and common stock option equity awards outstanding under three share-based compensation plans. As of June 30, 2014, we had approximately 4,800,000 shares reserved (inclusive of equity award forfeitures) and available for grant under the 2008 MedAssets, Inc. Long-Term Performance Incentive Plan (“LTPIP”).
	The total share-based compensation expense related to equity awards was $5,592 and $4,011 for the three months ended June 30, 2014 and 2013, respectively. The total income tax benefit recognized in the condensed consolidated statement of operations for share-based compensation arrangements related to equity awards was $2,083 and $1,501 for the three months ended June 30, 2014 and 2013, respectively.
	The total share-based compensation expense related to equity awards was $9,894 and $7,422 for the six months ended June 30, 2014 and 2013, respectively. The total income tax benefit recognized in the condensed consolidated statement of operations for share-based compensation arrangements related to equity awards was $3,686 and $2,778 for the six months ended June 30, 2014 and 2013, respectively. There were no capitalized share-based compensation expenses during the three and six months ended June 30, 2014.

	Total share-based compensation expense (inclusive of restricted common stock, RSUs, SSARs and common stock options) for the three and six months ended June 30, 2014 and 2013 as reflected in our condensed consolidated statements of operations is as follows:


			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Cost of revenue		$	1,863	$	1,463	$	3,029	$	2,176
	Product development			391		225		635		343
	Selling and marketing			845		590		1,372		969
	General and administrative			2,493		1,733		4,858		3,934

	Total share-based compensation expense		$	5,592	$	4,011	$	9,894	$	7,422

	Employee Stock Purchase Plan
	In 2010, we established the MedAssets, Inc. Employee Stock Purchase Plan (the “Plan”). Under the Plan, eligible employees may purchase shares of our common stock at a discounted price through payroll deductions. The price per share of the common stock sold to participating employees will be 95% of the fair market value of our common stock on the applicable purchase date. The Plan requires that all stock purchased be held by participants for a period of 18 months from the purchase date. A total of 500,000 shares of our common stock are authorized for purchase under the Plan. For the six months ended June 30, 2014 and 2013, we purchased approximately 11,000 shares and 11,700 shares of our common stock under the Plan which amounted to approximately $253 and $205, respectively.
	Equity Award Grants
	Information regarding equity awards for the six months ended June 30, 2014 is as follows:
	Restricted Stock Unit Equity Awards
	In February 2014, our Compensation Committee of our Board of Directors approved an equity grant for certain eligible employees consisting of service-based and performance-based RSUs. The purpose of the equity grant is to assist the Company in attracting, retaining, motivating, and rewarding certain individuals of the Company. The equity grant is intended to promote the creation of long-term value for stockholders of the Company by closely aligning the interests of such individuals with those of the stockholders. The total approved equity grant amounted to 1,218,826 RSUs with a grant date fair value of $25.06 per award and was comprised of: (i) 63,355 service-based RSUs that vest ratably each month through December 31, 2014; (ii) 469,011 service-based RSUs that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015; (iii) 343,230 performance-based RSUs using a net revenue performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved; and (iv) 343,230 performance-based RSUs using an adjusted EBITDA performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved.
	In May 2014, our Compensation Committee of our Board of Directors approved an equity grant for certain eligible employees consisting of service-based and performance-based RSUs. The total approved equity grant amounted to 8,982 RSUs with a grant date fair value of $23.54 per award and was comprised of: (i) 6,179 service-based RSUs that vest ratably each month through December 31, 2014; (ii) 2,107 service-based RSUs that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015; (iii) 348 performance-based RSUs using a net revenue performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved; and (iv) 348 performance-based RSUs using an adjusted EBITDA performance metric that vest annually over three years of continuous service with the first annual vest date beginning on March 1, 2015 provided the performance metric is achieved.
	The measurement period for the net revenue performance-based awards is from January 1, 2014 through December 31, 2014. The net revenue performance metric is based on the achievement of an established net revenue target. The Company must achieve a minimum threshold of net revenue before any performance-based RSUs begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.

	The measurement period for the adjusted EBITDA performance-based awards is from January 1, 2014 through December 31, 2014. The adjusted EBITDA performance metric is based on the achievement of an established adjusted EBITDA target. The Company must achieve a minimum threshold of adjusted EBITDA before any performance-based RSUs begin vesting. The equity award holders have an opportunity to earn between 50% and 100% of the performance-based equity awards once the minimum threshold has been met. If the minimum threshold is not met, the equity award holders will forfeit those awards.
	In May 2014, our Compensation Committee of our Board of Directors also approved an equity grant consisting of 100,000 performance-based RSUs using a net revenue performance metric that is a cliff-vesting award and is based on the achievement of a target cumulative annual growth rate over a three-year performance period. Depending on the cumulative revenue growth rate achieved, up to 200,000 RSUs can be earned. The RSUs have a grant date fair value of $23.54 per award and the measurement period is from January 1, 2014 through December 31, 2016. A certain minimum cumulative revenue growth rate must be achieved before any RSUs will vest on March 1, 2017. If the minimum threshold is not met, the equity award holder will forfeit the awards.

INCOME_TAXES

INCOME TAXES	6 Months Ended
	Jun. 30, 2014
Income Tax Disclosure [Abstract]	'
INCOME TAXES	'
	8	INCOME TAXES
	Income tax expense recorded during the three and six months ended June 30, 2014 reflected an effective income tax rate of 41.1% and 42.6%, respectively. Income tax expense recorded during the three and six months ended June 30, 2013 reflected an effective income tax rate of 38.4% and 38.9%, respectively.

INCOME_PER_SHARE

INCOME PER SHARE	6 Months Ended
INCOME PER SHARE	Jun. 30, 2014
Earnings Per Share [Abstract]	'
INCOME PER SHARE	'
	9	INCOME PER SHARE
	We calculate earnings per share (or “EPS”) in accordance with the GAAP relating to earnings per share. Basic EPS is calculated by dividing reported net income by the weighted-average number of common shares outstanding for the reported period following the two-class method. Diluted EPS reflects the potential dilution that could occur if our stock options, SSARs, unvested restricted stock, RSUs and shares that were purchasable pursuant to our employee stock purchase plan were exercised and converted into our common shares during the reporting periods.
	A reconciliation of basic and diluted weighted average shares outstanding for basic and diluted EPS for the three and six months ended June 30, 2014 and 2013 is as follows:


			Three Months Ended June 30,
			2014		2013
	Numerator for Basic and Diluted Income Per Share:
	Net income		$	6,596	$	5,084
	Denominator for basic income per share weighted average shares			59,752,000		59,387,000
	Effect of dilutive securities:
	Stock options			222,000		579,000
	SSARs			343,000		262,000
	Restricted stock and RSUs			629,000		437,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions			60,946,000		60,665,000
	Basic income per share:
	Basic net income from continuing operations		$	0.11	$	0.09

	Diluted net income per share:
	Diluted net income from continuing operations		$	0.11	$	0.08



			Six Months Ended June 30,
			2014		2013
	Numerator for Basic and Diluted Income Per Share:
	Net income		$	14,274	$	12,788
	Denominator for basic income per share weighted average shares			60,189,000		59,198,000
	Effect of dilutive securities:
	Stock options			282,000		671,000
	SSARs			330,000		307,000
	Restricted stock and RSUs			618,000		452,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions			61,419,000		60,628,000
	Basic income per share:
	Basic net income from continuing operations		$	0.24	$	0.22

	Diluted net income per share:
	Diluted net income from continuing operations		$	0.23	$	0.21

	During the three and six months ended June 30, 2014 and 2013, the effect of certain dilutive securities have been excluded because the impact is anti-dilutive as a result of certain securities being “out of the money” with strike prices greater than the average market price during the periods presented.
	The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


			Three Months Ended March 31,				Six Months Ended June 30,
			2014		2013		2014		2013
	Stock options			-		6,000		-		2,000
	SSARs			5,000		93,000		8,000		71,000

				5,000		99,000		8,000		73,000

SEGMENT_INFORMATION

SEGMENT INFORMATION	6 Months Ended
SEGMENT INFORMATION	Jun. 30, 2014
Segment Reporting [Abstract]	'
SEGMENT INFORMATION	'
	10	SEGMENT INFORMATION
	We manage our business through two reportable business segments, Spend and Clinical Resource Management (or “SCM”) and Revenue Cycle Management (or “RCM”).

		—		Spend and Clinical Resource Management. Our SCM segment provides a comprehensive suite of technology-enabled services that help our clients manage their expense categories. Our solutions lower supply and medical device pricing and utilization by managing the procurement process through our group purchasing organization (“GPO”) portfolio of contracts, consulting services and business intelligence tools.

		—		Revenue Cycle Management. Our RCM segment provides a comprehensive suite of products and services spanning the hospital revenue cycle workflow—from patient access and financial responsibility, charge capture and integrity, pricing analysis, claims processing and denials management, payor contract management, revenue recovery and accounts receivable services. Our workflow solutions, together with our data management, compliance and audit tools, increase revenue capture and cash collections, reduce accounts receivable balances and increase regulatory compliance.
	GAAP relating to segment reporting defines reportable segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing financial performance. The guidance indicates that financial information about segments should be reported on the same basis as that which is used by the chief operating decision maker in the analysis of performance and allocation of resources. Management of the Company, including our chief operating decision maker, uses what we refer to as Segment Adjusted EBITDA as its primary measure of profit or loss to assess segment performance and to determine the allocation of resources. We define Segment Adjusted EBITDA as segment net income (loss) before net interest expense, income tax expense (benefit), depreciation and amortization (“EBITDA”) as adjusted for other non-recurring, non-cash or non-operating items. Our chief operating decision maker uses Segment Adjusted EBITDA to facilitate a comparison of our operating performance on a consistent basis from period to period. Segment Adjusted EBITDA includes expenses associated with sales and marketing, general and administrative and product development activities specific to the operation of the segment. General and administrative corporate expenses that are not specific to the segments are not included in the calculation of Segment Adjusted EBITDA. These expenses include the costs to manage our corporate offices, interest expense on our credit facilities and expenses related to being a publicly-held company. All reportable segment revenues are presented net of inter-segment eliminations and represent revenues from external clients.
	The following tables present Segment Adjusted EBITDA and financial position information as utilized by our chief operating decision maker. A reconciliation of Segment Adjusted EBITDA to consolidated net income is included. General corporate expenses are included in the “Corporate” line item. “RCM” represents the Revenue Cycle Management segment and “SCM” represents the Spend and Clinical Resource Management segment. Other assets and liabilities are included to provide a reconciliation to total assets and total liabilities.
	The following tables represent our results of operations, by segment, for the three and six months ended June 30, 2014 and 2013:


			Three Months Ended						Six Months Ended
			June 30,						June 30,
			2014			2013			2014			2013
	Revenue:
	SCM
	Gross administrative fees(1)		$	119,406		$	115,488		$	245,767		$	236,124
	Revenue share obligation(1)			(49,315)			(44,986)			(99,430)			(89,103)

	Net administrative fees			70,091			70,502			146,337			147,021
	Other service fees(2)			35,816			34,806			68,187			67,795

	Total SCM net revenue			105,907			105,308			214,524			214,816
	RCM
	Revenue cycle technology			47,507			45,290			91,700			88,670
	Revenue cycle services			22,001			20,144			40,058			40,093

	Total RCM net revenue			69,508			65,434			131,758			128,763

	Total net revenue			175,415			170,742			346,282			343,579
	Operating expenses:
	SCM			81,813			82,708			158,256			164,397
	RCM			58,243			55,884			115,218			111,577
	Corporate			13,086			11,789			25,755			23,246

	Total operating expenses			153,142			150,381			299,229			299,220

	Operating income (loss):
	SCM			24,094			22,600			56,268			50,419
	RCM			11,265			9,550			16,540			17,186
	Corporate			(13,086)			(11,789)			(25,755)			(23,246)

	Total operating income			22,273			20,361			47,053			44,359

	Interest (expense)			(11,114)			(12,381)			(22,287)			(23,730)
	Other income			31			276			89			317

	Income before income taxes			11,190			8,256			24,855			20,946
	Income tax expense			4,594			3,172			10,581			8,158

	Net income		$	6,596		$	5,084		$	14,274		$	12,788

	Segment Adjusted EBITDA
	SCM		$	42,300		$	42,942		$	92,250		$	96,654
	RCM			19,613			17,022			33,014			31,712

	Total Segment Adjusted EBITDA		$	61,913		$	59,964		$	125,264		$	128,366
	Corporate			(7,589)			(7,427)			(14,223)			(14,183)

	Total Adjusted EBITDA(1)		$	54,324		$	52,537		$	111,041		$	114,183

		-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.
		-2	Other service fees primarily consists of consulting, services and technology fees.


		Six Months Ended
		June 30,
		2014			2013
Capital expenditures(1):
SCM		$	11,002		$	7,202
RCM			15,417			15,799
Corporate			1,660			1,188

Total		$	28,079		$	24,189

	-1	Capital expenditures consist of purchases of property and equipment and capitalized software development costs (internal and external use).


		June 30,			December 31,
		2014			2013
Financial Position:
Accounts receivable, net
SCM		$	44,648		$	38,319
RCM			53,245			49,314
Corporate			8			3

Total accounts receivable, net			97,901			87,636
Other assets
SCM			934,956			955,252
RCM			497,268			503,359
Corporate			70,415			67,502

Total other assets			1,502,639			1,526,113

Total assets		$	1,600,540		$	1,613,749
SCM accrued revenue share obligation		$	77,697		$	77,398
Deferred revenue
SCM			29,350			22,775
RCM			43,528			40,117

Total deferred revenue			72,878			62,892
Notes payable			461,750			439,500
Bonds payable			325,000			325,000
Other liabilities
SCM			24,697			36,393
RCM			19,082			26,113
Corporate			147,341			156,664

Total other liabilities			191,120			219,170

Total liabilities		$	1,128,445		$	1,123,960
GAAP for segment reporting requires that the total of the reportable segments’ measures of profit or loss be reconciled to the Company’s consolidated operating results. The following table reconciles Segment Adjusted EBITDA to consolidated net income for the three and six months ended June 30, 2014 and 2013:


		Three Months Ended June 30,						Six Months Ended June 30,
		2014			2013			2014			2013
SCM Adjusted EBITDA		$	42,300		$	42,942		$	92,250		$	96,654
RCM Adjusted EBITDA			19,613			17,022			33,014			31,712

Total Segment Adjusted EBITDA			61,913			59,964			125,264			128,366
Depreciation			(8,696)			(7,170)			(16,958)			(13,646)
Depreciation (included in cost of revenue)			(648)			(571)			(1,072)			(1,169)
Amortization of intangibles			(14,027)			(16,115)			(28,053)			(32,616)
Income tax expense			(14,562)			(12,395)			(30,952)			(26,305)
Share-based compensation expense(1)			(3,243)			(2,524)			(5,341)			(3,922)
Restructuring, acquisition and integration-related expenses(2)			-			(1,435)			(1,131)			(9,465)

Total reportable segment net income			20,737			19,754			41,757			41,243
Corporate net loss			(14,141)			(14,670)			(27,483)			(28,455)

Consolidated net income		$	6,596		$	5,084		$	14,274		$	12,788

	-1	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.
	-2	Represents the amount attributable to restructuring, acquisition and integration-related costs which may include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	6 Months Ended
	Jun. 30, 2014
Fair Value Disclosures [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	11	FAIR VALUE MEASUREMENTS
	We measure fair value for financial instruments when a valuation is necessary, such as for impairment of long-lived and indefinite-lived assets when indicators of impairment exist in accordance with GAAP for fair value measurements and disclosures. This defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measures required under other accounting pronouncements, but does not change existing guidance as to whether or not an instrument is carried at fair value.
	In estimating our fair value disclosures for financial instruments, we use the following methods and assumptions:

		—	Cash and cash equivalents. The carrying value reported in the condensed consolidated balance sheets for these items approximates fair value due to the high credit standing of the financial institutions holding these items and their liquid nature;

		—	Accounts receivable, net. The carrying value reported in the condensed consolidated balance sheets is net of allowances for doubtful accounts which includes a degree of counterparty non-performance risk;

		—	Accounts payable and current liabilities. The carrying value reported in the condensed consolidated balance sheets for these items approximates fair value, which is the likely amount for which the liability with short settlement periods would be transferred to a market participant with a similar credit standing as the Company;

		—	Notes payable. The carrying value of our long-term notes payable reported in the condensed consolidated balance sheets approximates fair value since they bear interest at variable rates. Refer to Note 5 for further information; and

		—	Bonds payable. The carrying value of our long-term bonds payable reported in the condensed consolidated balance sheets approximates fair value. Refer to Note 5 for further information.

RELATED_PARTY_TRANSACTION

RELATED PARTY TRANSACTION	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTION	'
	12	RELATED PARTY TRANSACTION
	We have an agreement with John Bardis, our chief executive officer, for the use of an airplane owned by JJB Aviation, LLC, a limited liability company, owned by Mr. Bardis. We pay Mr. Bardis at market-based rates for the use of the airplane for business purposes. The audit committee of the board of directors reviews such usage of the airplane annually. During the six months ended June 30, 2014 and 2013, we incurred charges of $756 and $1,130, respectively, related to transactions with Mr. Bardis.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2014
Subsequent Events [Abstract]	'
SUBSEQUENT EVENTS	'
	13	SUBSEQUENT EVENTS
	We have evaluated subsequent events for recognition or disclosure in the condensed consolidated financial statements filed on Form 10-Q with the SEC and no events have occurred that require disclosure, except for the following.
	In July 2014, we entered into a new operating lease agreement for approximately 108,000 square feet of office space in Alpharetta, Georgia. The lease term commences on or around January 1, 2016 with an initial term of fifteen years plus an option to extend the lease term for up to ten years. The total estimated rental commitment under the initial term of the lease agreement is approximately $41,624.

BUSINESS_DESCRIPTION_AND_BASIS1

BUSINESS DESCRIPTION AND BASIS OF PRESENTATION (Policies)	6 Months Ended
BUSINESS DESCRIPTION AND BASIS OF PRESENTATION (Policies)	Jun. 30, 2014
Accounting Policies [Abstract]	'
Use of Estimates	'
	Use of Estimates
	The preparation of the financial statements and related disclosures in conformity with GAAP and pursuant to the rules and regulations of the SEC, requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results may differ materially from those estimates. We believe that the estimates, assumptions and judgments involved in revenue recognition, allowances for doubtful accounts and returns, product development costs, share-based payments, business combinations, impairment of goodwill, intangible assets and long-lived assets, and accounting for income taxes have the greatest potential impact on our condensed consolidated financial statements.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	All of our highly liquid investments with original maturities of three months or less at the date of purchase are carried at cost which approximates fair value and are considered to be cash equivalents. Currently, our excess cash is voluntarily used to repay our swing line credit facility, if any, on a daily basis and applied against our revolving credit facility on a routine basis when our swing line credit facility is undrawn. In addition, we may periodically make voluntary repayments on our term loans.
	Cash and cash equivalents were $6,004 and $2,790 as of June 30, 2014 and December 31, 2013, respectively. We had $50,000 and $10,000 outstanding on our revolving credit facility as of June 30, 2014 and December 31, 2013, respectively. In the event our cash balance is zero at the end of a period, any outstanding checks are recorded as accrued expenses. See Note 5 for immediately available cash under our revolving credit facility.
	Additionally, we have a concentration of credit risk arising from cash deposits held in excess of federally insured amounts totaling $5,504 as of June 30, 2014.

DEFERRED_REVENUE_Tables

DEFERRED REVENUE (Tables)	6 Months Ended
DEFERRED REVENUE (Tables)	Jun. 30, 2014
Deferred Revenue Disclosure [Abstract]	'
Summary of Deferred Revenue	'
	The following table summarizes the deferred revenue categories and balances as of:


		June 30,		December 31,
		2014		2013
	Software and implementation fees	$	34,097	$	27,393
	Service fees		23,804		22,363
	Administrative fees		11,748		10,935
	Other fees		3,229		2,201

	Deferred revenue, total		72,878		62,892
	Less: Deferred revenue, current portion		(55,645)		(46,523)

	Deferred revenue, non-current portion	$	17,233	$	16,369

NOTES_AND_BONDS_PAYABLE_Tables

NOTES AND BONDS PAYABLE (Tables)	6 Months Ended
NOTES AND BONDS PAYABLE (Tables)	Jun. 30, 2014
Debt Disclosure [Abstract]	'
Summary of Notes Payable	'
	The balances of our notes and bonds payable are summarized as follows as of:


			June 30,		December 31,
			2014		2013
	Term A facility		$	231,250	$	237,500
	Term B facility			180,500		192,000
	Revolving credit facility			50,000		10,000

	Total notes payable			461,750		439,500
	Bonds payable			325,000		325,000

	Total notes and bonds payable			786,750		764,500
	Less: current portions			(18,625)		(15,500)

	Total long-term notes and bonds payable		$	768,125	$	749,000

Percentage of Redemption Prices	'
	The Company has the option to redeem the Notes as follows: (i) at any time prior to November 15, 2014, the Company may redeem all or part of the Notes at a redemption price equal to 100% of the principal amount plus the applicable premium (as defined in the Indenture); and (ii) on and after November 15, 2014, the Company may redeem all or a part of the Notes, at the following redemption prices:


	Year		Percentage
	2014			104%
	2015			102%
	2016 and thereafter			100%
Debt Maturities and Scheduled Principal Repayments	'
	The following table summarizes our stated debt maturities and scheduled principal repayments as of June 30, 2014:


	Year		Term A Facility		Term B Facility		Revolving Credit		Senior		Total
	Year		Term A Facility		Term B Facility		Facility		Unsecured Notes		Total
	2014		$	6,250	$	1,500	$	-	$	-	$	7,750	(1)
	2015			18,750		3,000		-		-		21,750
	2016			25,000		3,000		-		-		28,000
	2017			181,250		3,000		50,000		-		234,250
	2018			-		3,000		-		325,000		328,000
	Thereafter			-		167,000		-		-		167,000

			$	231,250	$	180,500	$	50,000	$	325,000	$	786,750


		-1	Represents the remaining quarterly principal payments due during the fiscal year ending December 31, 2014 and the balance of the swing line component of our revolving credit facility, if any.

STOCKHOLDERS_EQUITY_AND_SHAREB1

STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION (Tables)	6 Months Ended
STOCKHOLDERS' EQUITY AND SHARE-BASED COMPENSATION (Tables)	Jun. 30, 2014
Text Block [Abstract]	'
Summary of Amount and Cost of Common Stock Repurchased	'
	The following table shows the amount and cost of shares of common stock we repurchased for the three and six months ended June 30, 2014 under the share repurchase program. The repurchased shares have not been retired and constitute authorized but unissued shares.


			Three months ended June 30,				Six months ended June 30,
			2014		2013		2014		2013
	Number of shares repurchased			1,144,145		-		1,784,145		-
	Cost of shares repurchased(1)		$	26,699	$	-	$	42,759	$	-

		-1	Our share repurchase program required a three-day cash settlement period with our broker. We made purchases at the end of June 2014 amounting to 3,071 shares totaling approximately $67, which were settled in July 2014. The cost of these shares is included in other accrued expenses on our Condensed Consolidated Balance Sheet as of June 30, 2014.
Summary of Total Share-Based Compensation Expense	'
	Total share-based compensation expense (inclusive of restricted common stock, RSUs, SSARs and common stock options) for the three and six months ended June 30, 2014 and 2013 as reflected in our condensed consolidated statements of operations is as follows:


			Three Months Ended June 30,				Six Months Ended June 30,
			2014		2013		2014		2013
	Cost of revenue		$	1,863	$	1,463	$	3,029	$	2,176
	Product development			391		225		635		343
	Selling and marketing			845		590		1,372		969
	General and administrative			2,493		1,733		4,858		3,934

	Total share-based compensation expense		$	5,592	$	4,011	$	9,894	$	7,422

INCOME_PER_SHARE_Tables

INCOME PER SHARE (Tables)	6 Months Ended
INCOME PER SHARE (Tables)	Jun. 30, 2014
Earnings Per Share [Abstract]	'
Reconciliation of Basic and Diluted Weighted Average Shares Outstanding	'
	A reconciliation of basic and diluted weighted average shares outstanding for basic and diluted EPS for the three and six months ended June 30, 2014 and 2013 is as follows:


		Three Months Ended June 30,
		2014		2013
	Numerator for Basic and Diluted Income Per Share:
	Net income	$	6,596	$	5,084
	Denominator for basic income per share weighted average shares		59,752,000		59,387,000
	Effect of dilutive securities:
	Stock options		222,000		579,000
	SSARs		343,000		262,000
	Restricted stock and RSUs		629,000		437,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions		60,946,000		60,665,000
	Basic income per share:
	Basic net income from continuing operations	$	0.11	$	0.09

	Diluted net income per share:
	Diluted net income from continuing operations	$	0.11	$	0.08



		Six Months Ended June 30,
		2014		2013
	Numerator for Basic and Diluted Income Per Share:
	Net income	$	14,274	$	12,788
	Denominator for basic income per share weighted average shares		60,189,000		59,198,000
	Effect of dilutive securities:
	Stock options		282,000		671,000
	SSARs		330,000		307,000
	Restricted stock and RSUs		618,000		452,000

	Denominator for diluted income per share—adjusted weighted average shares and assumed conversions		61,419,000		60,628,000
	Basic income per share:
	Basic net income from continuing operations	$	0.24	$	0.22

	Diluted net income per share:
	Diluted net income from continuing operations	$	0.23	$	0.21

Summary of Potentially Dilutive Securities	'
	The following table provides a summary of those potentially dilutive securities that have been excluded from the above calculation of diluted EPS:


		Three Months Ended March 31,				Six Months Ended June 30,
		2014		2013		2014		2013
	Stock options		-		6,000		-		2,000
	SSARs		5,000		93,000		8,000		71,000

			5,000		99,000		8,000		73,000

SEGMENT_INFORMATION_Tables

SEGMENT INFORMATION (Tables)	6 Months Ended
SEGMENT INFORMATION (Tables)	Jun. 30, 2014
Segment Reporting [Abstract]	'
Financial Information of Business Segments	'
	The following tables represent our results of operations, by segment, for the three and six months ended June 30, 2014 and 2013:


			Three Months Ended					Six Months Ended
			June 30,					June 30,
			2014			2013		2014		2013
	Revenue:
	SCM
	Gross administrative fees(1)		$	119,406		$	115,488	$	245,767	$	236,124
	Revenue share obligation(1)			(49,315)			(44,986)		(99,430)		(89,103)

	Net administrative fees			70,091			70,502		146,337		147,021
	Other service fees(2)			35,816			34,806		68,187		67,795

	Total SCM net revenue			105,907			105,308		214,524		214,816
	RCM
	Revenue cycle technology			47,507			45,290		91,700		88,670
	Revenue cycle services			22,001			20,144		40,058		40,093

	Total RCM net revenue			69,508			65,434		131,758		128,763

	Total net revenue			175,415			170,742		346,282		343,579
	Operating expenses:
	SCM			81,813			82,708		158,256		164,397
	RCM			58,243			55,884		115,218		111,577
	Corporate			13,086			11,789		25,755		23,246

	Total operating expenses			153,142			150,381		299,229		299,220

	Operating income (loss):
	SCM			24,094			22,600		56,268		50,419
	RCM			11,265			9,550		16,540		17,186
	Corporate			(13,086)			(11,789)		(25,755)		(23,246)

	Total operating income			22,273			20,361		47,053		44,359

	Interest (expense)			(11,114)			(12,381)		(22,287)		(23,730)
	Other income			31			276		89		317

	Income before income taxes			11,190			8,256		24,855		20,946
	Income tax expense			4,594			3,172		10,581		8,158

	Net income		$	6,596		$	5,084	$	14,274	$	12,788

	Segment Adjusted EBITDA
	SCM		$	42,300		$	42,942	$	92,250	$	96,654
	RCM			19,613			17,022		33,014		31,712

	Total Segment Adjusted EBITDA		$	61,913		$	59,964	$	125,264	$	128,366
	Corporate			(7,589)			(7,427)		(14,223)		(14,183)

	Total Adjusted EBITDA(1)		$	54,324		$	52,537	$	111,041	$	114,183

		-1	These are non-GAAP measures. See “Use of Non-GAAP Financial Measures” section for additional information.
		-2	Other service fees primarily consists of consulting, services and technology fees.


			Six Months Ended
			June 30,
			2014			2013
	Capital expenditures(1):
	SCM		$	11,002		$	7,202
	RCM			15,417			15,799
Corporate			1,660			1,188

Total		$	28,079		$	24,189

	-1	Capital expenditures consist of purchases of property and equipment and capitalized software development costs (internal and external use).


		June 30,			December 31,
		2014			2013
Financial Position:
Accounts receivable, net
SCM		$	44,648		$	38,319
RCM			53,245			49,314
Corporate			8			3

Total accounts receivable, net			97,901			87,636
Other assets
SCM			934,956			955,252
RCM			497,268			503,359
Corporate			70,415			67,502

Total other assets			1,502,639			1,526,113

Total assets		$	1,600,540		$	1,613,749
SCM accrued revenue share obligation		$	77,697		$	77,398
Deferred revenue
SCM			29,350			22,775
RCM			43,528			40,117

Total deferred revenue			72,878			62,892
Notes payable			461,750			439,500
Bonds payable			325,000			325,000
Other liabilities
SCM			24,697			36,393
RCM			19,082			26,113
Corporate			147,341			156,664

Total other liabilities			191,120			219,170

Total liabilities		$	1,128,445		$	1,123,960
Segment Adjusted EBITDA to Consolidated Net Income	'
	The following table reconciles Segment Adjusted EBITDA to consolidated net income for the three and six months ended June 30, 2014 and 2013:


			Three Months Ended June 30,					Six Months Ended June 30,
			2014			2013		2014		2013
	SCM Adjusted EBITDA		$	42,300		$	42,942	$	92,250	$	96,654
	RCM Adjusted EBITDA			19,613			17,022		33,014		31,712

	Total Segment Adjusted EBITDA			61,913			59,964		125,264		128,366
	Depreciation			(8,696)			(7,170)		(16,958)		(13,646)
	Depreciation (included in cost of revenue)			(648)			(571)		(1,072)		(1,169)
	Amortization of intangibles			(14,027)			(16,115)		(28,053)		(32,616)
	Income tax expense			(14,562)			(12,395)		(30,952)		(26,305)
	Share-based compensation expense(1)			(3,243)			(2,524)		(5,341)		(3,922)
	Restructuring, acquisition and integration-related expenses(2)			-			(1,435)		(1,131)		(9,465)

	Total reportable segment net income			20,737			19,754		41,757		41,243
	Corporate net loss			(14,141)			(14,670)		(27,483)		(28,455)

	Consolidated net income		$	6,596		$	5,084	$	14,274	$	12,788

		-1	Represents non-cash share-based compensation to both employees and directors. We believe excluding this non-cash expense allows us to compare our operating performance without regard to the impact of share-based compensation, which varies from period to period based on amount and timing of grants.
		-2	Represents the amount attributable to restructuring, acquisition and integration-related costs which may include costs such as severance, retention, salaries relating to redundant positions, certain performance-related salary-based compensation, operating infrastructure costs and facility consolidation costs.

Recovered_Sheet1

Business Description and Basis of Presentation - Additional Information (Detail) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2013	Dec. 31, 2012
Accounting Policies [Abstract]	'	'	'	'
Maturity period of liquid instruments	'Three months or less	'	'	'
Cash and cash equivalents	$6,004	$2,790	$716	$13,734
Revolving credit facility	50,000	10,000	'	'
Concentration of credit risk arising from cash deposit held in excess of federally insured amounts	$5,504	'	'	'

Recovered_Sheet2

Restructuring Acquisition and Integration-Related Expenses - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Business Combinations [Abstract]	'	'	'	'	'
Charges incurred	$1,697	$0	$1,435	$1,697	$9,465
Cash payments	'	'	'	1,923	'
Restructuring reserve current	'	$394	'	$394	'

Deferred_Revenue_Summary_of_De

Deferred Revenue - Summary of Deferred Revenue (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	$72,878	$62,892
Less: Deferred revenue, current portion	-55,645	-46,523
Deferred revenue, non-current portion	17,233	16,369
Software and Implementation Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	34,097	27,393
Service Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	23,804	22,363
Administrative Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	11,748	10,935
Other Fees [Member]	'	'
Deferred Revenue Arrangement [Line Items]	'	'
Deferred revenue, total	$3,229	$2,201

Deferred_Revenue_Additional_In

Deferred Revenue - Additional Information (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Text Block [Abstract]	'	'
Contingent deferred revenue	$4,728	$6,516

Notes_and_Bonds_Payable_Summar

Notes and Bonds Payable - Summary of Notes Payable (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Total notes payable	$461,750	$439,500
Bonds payable	325,000	325,000
Total notes and bonds payable	786,750	764,500
Total notes and bonds payable	786,750	764,500
Less: current portions	-18,625	-15,500
Total long-term notes and bonds payable	768,125	749,000
Term A Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	231,250	237,500
Total notes and bonds payable	231,250	'
Total notes and bonds payable	231,250	'
Term B Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	180,500	192,000
Total notes and bonds payable	180,500	'
Total notes and bonds payable	180,500	'
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Total notes payable	50,000	10,000
Total notes and bonds payable	50,000	'
Total notes and bonds payable	$50,000	'

Notes_and_Bonds_Payable_Additi

Notes and Bonds Payable - Additional Information (Detail) (USD $)

3 Months Ended

6 Months Ended

In Thousands, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Dec. 31, 2013

Jun. 30, 2014

Nov. 30, 2010

Debt Instrument, Redemption, Period One [Member]

Maximum [Member]

Minimum [Member]

Revolving Credit Facility [Member]

Term B Facility [Member]

Term A Facility [Member]

Senior Notes Due 2018 [Member]

Debt Instrument [Line Items]

Notes payable

$461,750

$439,500

$50,000

$10,000

$180,500

$192,000

$231,250

$237,500

Amount drawn on revolving credit facility

50,000

Outstanding letter of credit under credit facility

149,000

Undrawn letters of credit outstanding amount

1,000

Scheduled principal payments

7,750

Voluntary prepayment on Term B Facility

10,000

Weighted average interest rate of senior term loan facility

2.49%

4.00%

2.49%

Percentage of consolidated tangible assets and revenues of subsidiaries not providing guarantees

2.50%

Percentage of consolidated earnings before interest taxes depreciation and amortization on consolidated basis of immaterial subsidiaries not providing guarantees

5.00%

Percentage of pledged equity securities of foreign subsidiary

65.00%

Principal amount of senior notes

325,000

Percentage owned by subsidiary guarantor

100.00%

Percentage of interest rate on bonds payable

8.00%

Maturity date of debt instrument

15-Nov-18

Percentage of principal amount for Redemption price

100.00%

Repurchase percentage of aggregate principal amount plus accrued and unpaid interest

101.00%

Percentage of par value on senior notes

105.80%

Debt issuance costs

15,385

Amortization of debt issuance costs

937

955

1,880

1,908

Total interest paid

$20,058

$23,577

Notes_and_Bonds_Payable_Percen

Notes and Bonds Payable - Percentage of Redemption Prices (Detail) (Senior Notes Due 2018 [Member])	6 Months Ended
	Jun. 30, 2014
2014 [Member]	'
Debt Instrument [Line Items]	'
Percentage of redemption prices	104.00%
2015 [Member]	'
Debt Instrument [Line Items]	'
Percentage of redemption prices	102.00%
2016 and thereafter [Member]	'
Debt Instrument [Line Items]	'
Percentage of redemption prices	100.00%

Notes_and_Bonds_Payable_Debt_M

Notes and Bonds Payable - Debt Maturities and Scheduled Principal Repayments (Detail) (USD $)	Jun. 30, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified	Jun. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Principal Payment in 2014	$7,750	'
Principal Payment in 2015	21,750	'
Principal Payment in 2016	28,000	'
Principal Payment in 2017	234,250	'
Principal Payment in 2018	328,000	'
Thereafter	167,000	'
Total notes and bonds payable	786,750	764,500
Term A Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2014	6,250	'
Principal Payment in 2015	18,750	'
Principal Payment in 2016	25,000	'
Principal Payment in 2017	181,250	'
Total notes and bonds payable	231,250	'
Term B Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2014	1,500	'
Principal Payment in 2015	3,000	'
Principal Payment in 2016	3,000	'
Principal Payment in 2017	3,000	'
Principal Payment in 2018	3,000	'
Thereafter	167,000	'
Total notes and bonds payable	180,500	'
Revolving Credit Facility [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2017	50,000	'
Total notes and bonds payable	50,000	'
Senior Unsecured Notes [Member]	'	'
Debt Instrument [Line Items]	'	'
Principal Payment in 2018	325,000	'
Total notes and bonds payable	$325,000	'

Recovered_Sheet3

Stockholders' Equity and Share-Based Compensation - Additional Information (Detail) (USD $)

3 Months Ended

6 Months Ended

12 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

6 Months Ended

1 Months Ended

In Thousands, except Share data, unless otherwise specified

Jun. 30, 2014

Jun. 30, 2013

Jun. 30, 2014

Jun. 30, 2013

Feb. 26, 2014

Jun. 30, 2014

Jun. 30, 2013

Dec. 31, 2010

31-May-14

Feb. 28, 2014

31-May-14

Jun. 30, 2014

31-May-14

Feb. 28, 2014

Jun. 30, 2014

31-May-14

Feb. 28, 2014

Jun. 30, 2014

31-May-14

Feb. 28, 2014

31-May-14

Feb. 28, 2014

Plans

SSARS Awards [Member]

Restricted Common Stock Awards [Member]

Employee Stock Purchase Plan [Member]

Performance-Based Restricted Shares [Member]

Performance-Based Restricted Shares Using EBITDA Performance Metric [Member]

Restricted Stock [Member]

Service-Based Restricted Shares Vesting Each Month Through December 31, 2013 [Member]

Service-Based Restricted Shares [Member]

Executive Officer [Member]

Minimum [Member]

Maximum [Member]

Minimum [Member]

Maximum [Member]

Executive Officer [Member]

Equity [Line Items]

Stock issued in connection with exercise of stock options

295,000

Aggregate exercise price of stock issued in connection with exercise of stock options

$2,559

Forfeited, Shares

44,000

Restricted shares that surrendered from equity awards holders

118,000

Associated minimum statutory tax liability, shares surrendered

2,832

Authorized amount for share repurchase program, maximum

75,000

Shares reserved under 2008 equity incentive plan available for grant

4,800,000

500,000

348

343,230

100,000

348

343,230

8,982

1,218,826

6,179

63,355

2,107

469,011

Number of share based compensation plans

Share-based compensation expense

5,592

4,011

9,894

7,422

Income tax benefit recognized from equity awards

$2,083

$1,501

$3,686

$2,778

Percentage of price per share of the common stock sold to participating employees

95.00%

Period required for holding stock purchases as per the plan

'18 months

Shares of common stock purchased

11,000

11,700

Shares of common stock purchased, amount

$253

$205

Weighted average grant date fair value, Granted

$23.54

$25.06

Share-based payment award, award vesting period

'3 years

Percentage to earn from performance-based equity awards

50.00%

100.00%

50.00%

100.00%

Shares issuable to equity holders depending on cumulative revenue growth rate

200,000

Recovered_Sheet4

Stockholders' Equity and Share-Based Compensation - Summary of Amount and Cost of Common Stock Repurchased (Detail) (USD $)	3 Months Ended	6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2014
Equity [Abstract]	'	'
Number of shares repurchased	1,144,145	1,784,145
Cost of shares repurchased	$26,699	$42,759

Stockholders_Equity_and_ShareB2

Stockholders' Equity and Share-Based Compensation - Summary of Amount and Cost of Common Stock Repurchased (Parenthetical) (Detail) (USD $)	6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014
Equity [Abstract]	'
Number of cash settlement days	'3 days
Shares purchased	3,071
Shares purchased, value	$67

Stockholders_Equity_and_ShareB3

Stockholders' Equity and Share-Based Compensation - Summary of Total Share-Based Compensation Expense (Detail) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	$5,592	$4,011	$9,894	$7,422
Cost of Revenue [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	1,863	1,463	3,029	2,176
Product Development [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	391	225	635	343
Selling and Marketing [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	845	590	1,372	969
General and Administrative [Member]	'	'	'	'
Shareholders Equity And Share Based Payments [Line Items]	'	'	'	'
Total share-based compensation expense	$2,493	$1,733	$4,858	$3,934

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail)	3 Months Ended		6 Months Ended
Income Taxes - Additional Information (Detail)	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Effective income tax rate	41.10%	38.40%	42.60%	38.90%

Income_Per_Share_Reconciliatio

Income Per Share - Reconciliation of Basic and Diluted Weighted Average Shares Outstanding (Detail) (USD $)	3 Months Ended		6 Months Ended
In Thousands, except Share data, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Numerator for Basic and Diluted Income Per Share:	'	'	'	'
Net income	$6,596	$5,084	$14,274	$12,788
Denominator for basic income per share weighted average shares	59,752,000	59,387,000	60,189,000	59,198,000
Effect of dilutive securities:	'	'	'	'
Stock options	222,000	579,000	282,000	671,000
SSARs	343,000	262,000	330,000	307,000
Restricted stock and RSUs	629,000	437,000	618,000	452,000
Denominator for diluted income per share - adjusted weighted average shares and assumed conversions	60,946,000	60,665,000	61,419,000	60,628,000
Basic income per share:	'	'	'	'
Basic net income from continuing operations	$0.11	$0.09	$0.24	$0.22
Diluted net income per share:	'	'	'	'
Diluted net income from continuing operations	$0.11	$0.08	$0.23	$0.21

Income_Per_Share_Summary_of_Po

Income Per Share - Summary of Potentially Dilutive Securities (Detail)	3 Months Ended		6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Jun. 30, 2014	Jun. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	5,000	99,000	8,000	73,000
Stock Options [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	'	6,000	'	2,000
Stock Appreciation Rights (SARs) [Member]	'	'	'	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'	'	'	'
Potentially dilutive securities	5,000	93,000	8,000	71,000

Segment_Information_Additional

Segment Information - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2014
	Segment
Segment Reporting [Abstract]	'
Number of reportable business segments	2

Segment_Information_Financial_

Segment Information - Financial Information of Business Segments (Detail) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Dec. 31, 2013
Revenue:	'	'	'	'	'
Net administrative fees	$70,091	$70,502	$146,337	$147,021	'
Other service fees	105,324	100,240	199,945	196,558	'
Total net revenue	175,415	170,742	346,282	343,579	'
Operating expenses:	'	'	'	'	'
Total operating expenses	153,142	150,381	299,229	299,220	'
Operating income (loss):	'	'	'	'	'
Total operating income	22,273	20,361	47,053	44,359	'
Interest expense	-11,114	-12,381	-22,287	-23,730	'
Other income	31	276	89	317	'
Income before income taxes	11,190	8,256	24,855	20,946	'
Income tax expense	4,594	3,172	10,581	8,158	'
Net income	6,596	5,084	14,274	12,788	'
Segment Adjusted EBITDA	'	'	'	'	'
Total Adjusted EBITDA	54,324	52,537	111,041	114,183	'
Capital expenditures :	'	'	'	'	'
Total Capital expenditures	'	'	28,079	24,189	'
Accounts receivable, net	'	'	'	'	'
Total accounts receivable, net	97,901	'	97,901	'	87,636
Other assets	'	'	'	'	'
Total other assets	1,502,639	'	1,502,639	'	1,526,113
Total assets	1,600,540	'	1,600,540	'	1,613,749
SCM accrued revenue share obligation	77,697	'	77,697	'	77,398
Deferred revenue	'	'	'	'	'
Total deferred revenue	72,878	'	72,878	'	62,892
Notes payable	461,750	'	461,750	'	439,500
Bonds payable	325,000	'	325,000	'	325,000
Other liabilities	'	'	'	'	'
Total other liabilities	191,120	'	191,120	'	219,170
Total liabilities	1,128,445	'	1,128,445	'	1,123,960
Operating Segments [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Total net revenue	175,415	170,742	346,282	343,579	'
Operating income (loss):	'	'	'	'	'
Interest expense	-11,114	-12,381	-22,287	-23,730	'
Other income	31	276	89	317	'
Income tax expense	4,594	3,172	10,581	8,158	'
Net income	6,596	5,084	14,274	12,788	'
Segment Adjusted EBITDA	'	'	'	'	'
Total Segment Adjusted EBITDA	61,913	59,964	125,264	128,366	'
Other assets	'	'	'	'	'
SCM accrued revenue share obligation	77,697	'	77,697	'	77,398
Deferred revenue	'	'	'	'	'
Total deferred revenue	72,878	'	72,878	'	62,892
Notes payable	461,750	'	461,750	'	439,500
Bonds payable	325,000	'	325,000	'	325,000
Corporate [Member]	'	'	'	'	'
Operating expenses:	'	'	'	'	'
Total operating expenses	13,086	11,789	25,755	23,246	'
Operating income (loss):	'	'	'	'	'
Total operating income	-13,086	-11,789	-25,755	-23,246	'
Net income	-14,141	-14,670	-27,483	-28,455	'
Segment Adjusted EBITDA	'	'	'	'	'
Total Adjusted EBITDA	-7,589	-7,427	-14,223	-14,183	'
Capital expenditures :	'	'	'	'	'
Total Capital expenditures	'	'	1,660	1,188	'
Accounts receivable, net	'	'	'	'	'
Total accounts receivable, net	8	'	8	'	3
Other assets	'	'	'	'	'
Total other assets	70,415	'	70,415	'	67,502
Other liabilities	'	'	'	'	'
Total other liabilities	147,341	'	147,341	'	156,664
SCM [Member] \| Operating Segments [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Gross administrative fees	119,406	115,488	245,767	236,124	'
Revenue share obligation	-49,315	-44,986	-99,430	-89,103	'
Net administrative fees	70,091	70,502	146,337	147,021	'
Other service fees	35,816	34,806	68,187	67,795	'
Total net revenue	105,907	105,308	214,524	214,816	'
Operating expenses:	'	'	'	'	'
Total operating expenses	81,813	82,708	158,256	164,397	'
Operating income (loss):	'	'	'	'	'
Total operating income	24,094	22,600	56,268	50,419	'
Segment Adjusted EBITDA	'	'	'	'	'
Total Segment Adjusted EBITDA	42,300	42,942	92,250	96,654	'
Total Adjusted EBITDA	42,300	42,942	92,250	96,654	'
Capital expenditures :	'	'	'	'	'
Total Capital expenditures	'	'	11,002	7,202	'
Accounts receivable, net	'	'	'	'	'
Total accounts receivable, net	44,648	'	44,648	'	38,319
Other assets	'	'	'	'	'
Total other assets	934,956	'	934,956	'	955,252
Deferred revenue	'	'	'	'	'
Total deferred revenue	29,350	'	29,350	'	22,775
Other liabilities	'	'	'	'	'
Total other liabilities	24,697	'	24,697	'	36,393
RCM [Member] \| Operating Segments [Member]	'	'	'	'	'
Revenue:	'	'	'	'	'
Revenue cycle technology	47,507	45,290	91,700	88,670	'
Revenue cycle services	22,001	20,144	40,058	40,093	'
Total net revenue	69,508	65,434	131,758	128,763	'
Operating expenses:	'	'	'	'	'
Total operating expenses	58,243	55,884	115,218	111,577	'
Operating income (loss):	'	'	'	'	'
Total operating income	11,265	9,550	16,540	17,186	'
Segment Adjusted EBITDA	'	'	'	'	'
Total Segment Adjusted EBITDA	19,613	17,022	33,014	31,712	'
Total Adjusted EBITDA	19,613	17,022	33,014	31,712	'
Capital expenditures :	'	'	'	'	'
Total Capital expenditures	'	'	15,417	15,799	'
Accounts receivable, net	'	'	'	'	'
Total accounts receivable, net	53,245	'	53,245	'	49,314
Other assets	'	'	'	'	'
Total other assets	497,268	'	497,268	'	503,359
Deferred revenue	'	'	'	'	'
Total deferred revenue	43,528	'	43,528	'	40,117
Other liabilities	'	'	'	'	'
Total other liabilities	$19,082	'	$19,082	'	$26,113

Segment_Information_Segment_Ad

Segment Information - Segment Adjusted Ebitda Consolidated Net Income (Detail) (USD $)	3 Months Ended		6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Depreciation	($11,862)	($9,876)	($23,402)	($19,053)
Amortization of intangibles	-14,027	-16,115	-28,053	-32,616
Income tax expense	-4,594	-3,172	-10,581	-8,158
Share-based compensation expense	-5,592	-4,011	-9,894	-7,422
Net (loss) income	6,596	5,084	14,274	12,788
Operating Segments [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total Segment Adjusted EBITDA	61,913	59,964	125,264	128,366
Income tax expense	-4,594	-3,172	-10,581	-8,158
Net (loss) income	6,596	5,084	14,274	12,788
Operating Segments [Member] \| SCM [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total Segment Adjusted EBITDA	42,300	42,942	92,250	96,654
Operating Segments [Member] \| RCM [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Total Segment Adjusted EBITDA	19,613	17,022	33,014	31,712
Operating Segments [Member] \| Reportable Segment [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Net (loss) income	20,737	19,754	41,757	41,243
Segment Reporting Reconciling Items [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Depreciation	-8,696	-7,170	-16,958	-13,646
Depreciation (included in cost of revenue)	-648	-571	-1,072	-1,169
Amortization of intangibles	-14,027	-16,115	-28,053	-32,616
Income tax expense	-14,562	-12,395	-30,952	-26,305
Share-based compensation expense	-3,243	-2,524	-5,341	-3,922
Restructuring, acquisition and integration-related expenses	'	-1,435	-1,131	-9,465
Corporate [Member]	'	'	'	'
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]	'	'	'	'
Net (loss) income	($14,141)	($14,670)	($27,483)	($28,455)

Related_Party_Transaction_Addi

Related Party Transaction - Additional Information (Detail) (USD $)	6 Months Ended
In Thousands, unless otherwise specified	Jun. 30, 2014	Jun. 30, 2013
Related Party Transactions [Abstract]	'	'
Charges incurred with respect to transactions with Mr. Bardis	$756	$1,130

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (GEORGIA, Office Building [Member], Subsequent Event [Member], USD $)	1 Months Ended
In Thousands, unless otherwise specified	Jul. 31, 2014
	sqft
GEORGIA \| Office Building [Member] \| Subsequent Event [Member]	'
Subsequent Event [Line Items]	'
Office space area under operating lease agreement	108,000
Operating lease term commence date	1-Jan-16
Initial operating lease term	'15 years
Maximum extend lease term	'10 years
Total estimated rental commitment under lease agreement	$41,624